Bacitracin

Ophthalmic
Topical
Class
Antibiotics
Subclass
Polypeptides
Substance name
Bacitracin
Brand names
Bacitraycin®
Common formulations
Ophthalmic ointment
Dosage and administration
Adults patients
Treatment of superficial ocular infections
•
1 ribbon(s) OPHTH q8-24h
Indications for use
Labeled indications
Adults
•
Treatment of superficial ocular infections
Safety risks
Contraindications
Hypersensitivity to bacitracin or its components
Intraocular infections
•
Do not use bacitracin for the treatment of deep-seated ocular infections or infections likely to become systemic.
Warnings and precautions
Superinfection
•
Maintain a high level of suspicion, as prolonged use of bacitracin may result in overgrowth of non-susceptible organisms particularly fungi.
Specific populations
Renal impairment
eGFR 0-90 mL/min/1.73 m²
•
Use acceptable. No dose adjustment required.
Renal replacement therapy
Any modality
•
Use acceptable. No dose adjustment required.
Hepatic impairment
Any severity
•
Use acceptable. No dose adjustment required.
Pregnancy and breastfeeding
Pregnancy
All trimesters
•
Insufficient evidence.
Breastfeeding
Acceptable for use during breastfeeding.
Unlikely excreted in breastmilk.
Unknown drug levels in breastfed infants.
Adverse reactions
Unknown frequency
•
Fungal ophthalmic infection, skin rash, allergic reactions
Interactions
Drug(s)
Check Interactions
Reset

What did you think about this content?

Create free account

Sign up for free to access the full drug resource